medigraphic.com
Boletín Clínico de la Asociación Médica del Hospital Infantil del Estado de Sonora

2016, Number 2

<< Back Next >>

Bol Clin Hosp Infant Edo Son 2016; 33 (2)

Nonsteroidal anti-inflamatory and their therapeutic applications (Part 1)

Perea-Martínez A, López-Navarrete G, de la Osa-Busto M, Reyes-Gómez U

Language: Spanish
References: 27
Page: 73-82
PDF size: 293.43 Kb.


ABSTRACT

This brief review aims to describe in a specific and practical manner, a proposal for the basic knowledge necessary in prescribing the big amount of drugs that constitute the group of Nonsteroidal Anti-inflammatory Drugs (NSAIDs), thereby forming a scientific basis for a better use, professional prescription and above all, offer the greatest possible safety for those who consume and prescribe them, and even more in the case of children in whom their enzyme systems, especially the liver enzymes, are totally different from the adult.


REFERENCES

  1. Machowiak PA. Concepts of fever. Arch Intern Med. 1998; 158: 1870-1881.

  2. Polat M, Kara SS, Tezer H, Tapisit A, Derinoz O, Dolgun A. A current analysis of caregiver´s approaches to fever and antipyretic usage. J Infect Dev Ctries. 2014; 8: 365-371.

  3. Royal College of Paediatric and Child Health. NICE 2013 Clinical guideline 2013 Feverish illness in children: assessment and initial management in children younger than 5 year. guidance.nice.org.uk/cg160

  4. International Association for the Study of Pain (IASP): Subcommittee on Taxonomy. Pain terms: a list with definitions and notes on usage. Pain. 1979; 6: 249-252.

  5. Committee on Advancing Pain Research, Care, and Education; Institute of Medicine. Relieving Pain in America. Washington, DC, USA: National Academies Press; 2011.

  6. Reid KJ, Harker J, Bala MM, et al. Epidemiology of chronic non-cancer pain in Europe: narrative review of prevalence, pain treatments and pain impact. Curr Med Res Opin. 2011; 27 (2): 449–462.

  7. Larsen GL, Henson PM. Mediators of inflammation. Immunol. 1983; 1: 335-359.

  8. Meek IL, van de Laar AFJ, Vonkeman HE. Non-Steroidal Anti-Inflammatory Drugs: An Overview of Cardiovascular Risks. Pharmaceuticals. 2010; 3: 2146-2162.

  9. The American Academy of Pain Medicine. Use of Opiods for the Treatment of Chronic Pain. 2013: 1-4. http://www. painmed.org/files/use-of-opioids-for-the-treatment-of-chronic-pain.pdf

  10. Hooten WM, Timming R, Belgrade M, Gaul J, Goertz M, Haake B, et al. Institute for Clinical Systems Improvement. Assessment and Management of Chronic Pain. Updated November 2013 World Health Organization. Essential medicines and health products. Treatment Guidelines on Pain. http://www.who.int/medicines/areas/quality_safety/3PedPainGLs_ coverspanish.pdf?ua=1

  11. Koes BW, van Tulder M, Christine CH. et al. An updated overview of clinical guidelines for the management of non-specific low back pain in primary care. Eur Spine J. 2010; 19: 2075–2094.

  12. Chou R, Huffman LH. Medications for acute and chronic low back pain: A review of the evidence for an American Pain Society/American Collge of Physicians Clinical Practice Guideline. Ann Intern Med. 2007; 147 (7): 505–514.

  13. Chou R, Deyo R, Friedly J, Skelly A, Hashimoto R, Weimer M, et al. Noninvasive Treatments for Low Back Pain. Comparative Effectiveness Review No. 169. (Prepared by the Pacific Northwest Evidence-based Practice Center under Contract No. 290-2012-00014-I.) AHRQ Publication No. 16-EHC004-EF. Rockville, MD: Agency for Healthcare Research and Quality; February 2016. www.effectivehealthcare.ahrq.gov/reports/final.cfm.

  14. Kanabar D. A Practical Approach to the treatment of Low-Risk Childhood Fever. Drugs. 2014; 14: 45-55.

  15. De Martino M, Chiarugi A. Recent Advances in Pediatric Use of Oral Paracetamol in Fever and Pain Management. Pain Ther. 2015; 4: 149–168.

  16. Paul IM, Sturgis SA, Yang Ch. Efficacy of Estandar Doses of Ibuprofen Alone, Alternanting, and Combined With Acetaminophen for the Treatment of Febrile Children. Clin Ther. 2010; 32 (14): 2433– 2440.

  17. FitzGerald GA. Coxibs and Cardiovascular Disease. N Engl J Med. 2004; 351: 1709–1711.

  18. DeRuiter. Non Steroidal Antiinflammatory Drugs. Principles of Drug Action 2, Fall; 2002.

  19. Qandil AM. Prodrugs of Nonsteroidal Anti-Inflammatory Drugs (NSDAIs), More Than Meets the Eye: A critical Review. Int J Mol Sci. 2012; 13: 17244-17274. Wallace JL. Mechanisms, prevention and clinical implications of nonsteroidal anti-inflammatory drug-enteropathy. World J Gastroenterol. 2013; 19 (12): 1861–1876.

  20. Patrono C, Baigent C. Nonsteroidal Anti-Inflammatory Drugs and the Heart. Circulation. 2014; 129: 907–916.

  21. Harirforoosh S, Asghar W, Jamali F. Adverse effects of nonsteroidal antiinflammatory drugs: an update of gastrointestinal, cardiovascular and renal complications. J Pharm Pharm Sci. 2013; 16 (5): 821–847.

  22. Bruno A, Tacconelli S, Patrignani P. Variability in the response to non-steroidal anti-inflammatory drugs: Mechanisms and Perspectives. Basic Clin Pharmacol Toxicol. 2014; 114: 56–63.

  23. Perea MA, Loredo AA. Tratamiento de la fiebre, la inflamación y el dolor en niños. PAC PEDIATRÍA - 3. Academia Mexicana de Pediatría A. C. Edit. Intersistemas; 2004

  24. Ashley NT, Weil ZM, Nelson RJ. Inflammation: Mechanisms, Costs, and Natural variation. Annu Rev Evol Syst. 2012; 43: 385–406.

  25. Garland EL. Pain Processing in the Human Nervous System: A selective review of nociceptive and Biobehavioral Pathways. Prim Care. 2012; 39 (3): 561–571.

  26. Ridderikhof ML, Lirk P, Schep NW, et al. The PanAM study: a multi-center, double-blinded, randomized, non-inferiority study of paracetamol versus non-steroidal anti-inflammatory drugs in treating acute musculoskeletal trauma. BioMed Central (BMC). Emergency Medicine. 2013; 13: 19. http://www.biomedcentral.com/1471-227X/13/19

  27. Antman EM, Bennett JS, Daugherty A, et al. Use of Nonsteroidal Antiinflammatory Drugs. An Update for clinicians. A Scientific Statement from the American Heart Association. Circulation. 2007; 115: 1634–1642.




2020     |     www.medigraphic.com